(Q34452735)

2 August 2017

1 reference

title

Alemtuzumab: a novel monoclonal antibody (English)

1 reference

2 August 2017

1 reference

1 reference

Ferrajoli A

1

1 reference

2 August 2017

O'Brien S

series ordinal

2

1 reference

2 August 2017

Keating MJ

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1059-1065

1 reference

Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Reshaping human antibodies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

FDA panel recommends two new cancer drugs for approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Campath-1H monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.6.1059

10.1517/14712598.1.6.1059

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference